1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol has been researched along with Nervous System Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barenholz, Y; Biegon, A; Brewster, ME; Korablyov, V; Mechoulam, R; Nadler, V; Pop, E; Soti, F | 1 |
| Eisen, A; Feigenbaum, JJ; Mechoulam, R; Seltzer, Z; Zeltser, R | 1 |
2 other study(ies) available for 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol and Nervous System Disorders
| Article | Year |
|---|---|
Derivatives of dexanabinol. II. Salts of amino acid esters containing tertiary and quaternary heterocyclic nitrogen with increased water-solubility.
Topics: Animals; Binding, Competitive; Cells, Cultured; Dizocilpine Maleate; Dogs; Dronabinol; Drug Stability; Excitatory Amino Acid Antagonists; Humans; Hydrolysis; Morpholines; Nervous System Diseases; Neurons; Neuroprotective Agents; Piperazines; Prodrugs; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Solubility; Structure-Activity Relationship; Tritium; Water | 1996 |
Suppression of neuropathic pain behavior in rats by a non-psychotropic synthetic cannabinoid with NMDA receptor-blocking properties.
Topics: Animals; Behavior, Animal; Body Weight; Copper; Dronabinol; Drug Interactions; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Motor Activity; Nervous System Diseases; Pain; Pain Measurement; Rats; Receptors, N-Methyl-D-Aspartate | 1991 |